Bottom line
ARBITER is a strong clinical pre-submission tool. Fukurō serves a broader academic audience on subscription credit allowances, plus figure evaluation, guideline audits, rebuttal analysis, and version comparison on Complete. Clinical researchers doing occasional reviews may prefer ARBITER's free first review; active researchers across disciplines often get better flexibility from Fukurō.
Feature comparison
| Feature | Fukurō | ARBITER |
|---|---|---|
| Subscription plans | ✓ | — |
| Full manuscript review | ✓ | ✓ |
| Rebuttal analysis | Complete | — |
| Version comparison | Complete | — |
| Citation verification | ~ | ✓ |
| Figure analysis | Complete | — |
| Journal-fit scoring | — | — |
✓ included · ~ partial · Complete = Complete plan only · — not offered
Comparison methodology: Features were evaluated using publicly available product information at the time of review. “Partial” indicates that the capability is limited, indirect, or available only in part of the workflow. Last reviewed: July 2026. Product information may change.
ARBITER: strengths
- Free first review, no credit card
- Physician-scientist calibrated for clinical research
- Credits never expire
- Separate abstract evaluation tier
- Citation audit across CrossRef, PubMed, and OpenAlex with retraction flagging
- SOC 2 Type II and ISO 27001 certified, with a HIPAA BAA available
ARBITER: gaps
- No subscription; volume savings come from multi-review packs
- Requires a methods section, so it is not suited to humanities or purely theoretical work
- No rebuttal analysis or manuscript version comparison
- AI-only with no human validation tier
Key limitation: Strongest in clinical and biomedical work; they state it can evaluate any scientific manuscript with a methods section. Reviews are purchased one at a time. No subscription, rebuttal workflow, or version comparison.
Frequently Asked
Is ARBITER better for medical papers?
ARBITER is calibrated for physician-scientist workflows. Fukurō covers methodology and clarity across disciplines but does not specialize in clinical trial reporting the way ARBITER does.
Which suits occasional versus active reviewing?
ARBITER sells single reviews after a free first one, which suits occasional use. Fukurō is a subscription with credit allowances that cover one to two active manuscripts; shorter manuscripts use fewer credits.
A second read, before you send
Reviewer-style feedback on what to strengthen, grounded in the criteria journal reviewers actually apply.